This opportunity is closed.The response deadline was Mar 6, 2026.
National Institutes of Health
Set-Aside
Full & Open
Competition
Full And Open
Award Type
Grant
Period of Performance
UG3 Phase (planning/feasibility) followed by UH3 Phase (clinical trial execution)
Number of Awards
multiple
NIH SIREN program seeks clinical trial proposals for neurologic conditions requiring UG3 phase (planning/feasibility study) followed by UH3 phase (full clinical trial execution). Applicants must demonstrate research team expertise, secure IRB approval, outline regulatory pathway, and provide detailed clinical protocol with patient recruitment and retention strategies.
Estimated team size: 10+
Clearance
None
Delivery Type
R&D
Complexity
High
Remote Eligible
Hybrid
Travel
National Institutes of Health
[email protected]301-402-2541Secondary POC
NIH Grants Information [email protected]
Sign in to view market intelligence, competition analysis, and spending data.
Sign InModerate
Evaluation
Best Value
Submission Complexity
Complex
Past Performance Req.
Yes
Incumbent Advantage
None
Protest Risk
Low
Follow-On Potential
Yes
Data Rights
Government Purpose
Certifications Required
Contract Vehicles Mentioned
If you're interested in this contract, you may also want to bid on these.
National Institutes of Health
National Institutes of Health
National Institutes of Health
National Institutes of Health
National Institutes of Health
National Institutes of Health
Similar contracts that have recently closed — useful for research and frequency analysis.
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional)
National Institutes of Health
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional)
National Institutes of Health
NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required)
National Institutes of Health
Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)
National Institutes of Health
Similar contracts are posted regularly. Set up alerts to get notified when matching contracts appear.
Get alerts for contracts like this →Browse more opportunities in this category to find your next bid.